Company intelligence / Profile preview

Boke

Wuxi, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Boke Bioscience is a biotechnology company based in Wuxi, China, specializing in high-throughput nucleic acid synthesis and advanced DNA technology. The company has developed a comprehensive synthetic biology platform that covers the entire process from oligonucleotide and DNA/RNA sequence synthesis to chromosome gene construction. Boke Bioscience provides critical tools and services for medical institutions, focusing on applications in precision medicine, clinical diagnosis, and biotherapy. By combining synthetic biology with genomic approaches, the company aims to accelerate research and commercial applications in the life sciences sector.

Therapeutic areas: OncologyImmunologyOther
Modalities: Synthetic oligonucleotideDNA sequencingRNA sequencing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Boke.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boke.

Explore the full profile